Skip to main content
OpenTrials
Completed

NCT Number: NCT02669420

Misoprostol for Second Trimester Pregnancy Termination

The majority of second-trimester pregnancy termination performed in the United States are performed surgically by dilation and evacuation. The frequency of induction of abortion increases as gestational age advances. In the late second trimester and early third trimester, induction is the primary method of termination in cases of fetal abnormalities. In many other countries, however, induction is the primary method of abortion throughout the second trimester

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intra Uterine Fetal Death

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnancy 13-24 weeks.
  • Women with indication for termination of the pregnancy due to intra uterine fetal death

Exclusion criteria

-Pregnancy before 13 weeks.

  • Pregnancy beyond 24 weeks.
  • Women with scared uterus.
  • Known hypersensitivity for misoprostol.
  • Refusal of the woman to participate.

Treatment and study plan

termination of second trimester pregnancy

Procedure

Intra uterine extra amniotic (200 μg ) versus Vaginal (200 μg) Misoprostol for Second Trimester Pregnancy Termination. Randomized controlled trial

Primary outcomes

  1. mean duration from the initial misoprostol dose until complete fetal expulsion

    Time frame: 24 hours

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Intra Uterine Extra Amniotic (200 μg ) Versus Vaginal (200 μg) Misoprostol for Second Trimester Pregnancy Termination: Randomized Controlled Trial

Acronym: MIS

Important dates

Study start
2015
Primary completion
2015
Study completion
2016
First posted
Feb 1, 2016
Registry last updated
Feb 1, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.